Focusing on Site Relationships to Foster Remote Visit Adoption:
The pandemic has evoked change in Decentralized Clinical Trial solutions and adaptation. Remote visits successfully address some of the site’s challenges and limitations by bringing the study to the participants, as opposed to bringing the participants to the site. PCM TRIALS will be discussing why sites may be resistant to remote visits, best practices to address these concerns, and the role home visit vendors play in the solution.

Presented by Ellen Weiss, VP of Business Development and Julie Church-Thomas, Director of Site Relations.

Key Points:
• Understand the potential concerns sites may have with remote visits
• Determine ways you can address these concerns
• Learn how to successfully roll out remote visits to your sites